Angiographic and clinical outcomes after rescue coronary stenting

Catheterization and Cardiovascular Interventions

Volumn 50, Issue 3, 2000, Pages 269-275

  Dauerman, Harold L ^a,c   Prpic, Ross ^b   Andreou, Costa ^a   Vu, Mary A ^a   Popma, Jeffrey J ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Angioplasty; Stenting; Thrombolysis

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; HEART CATHETERIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MORTALITY; SAFETY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; HOSPITAL MORTALITY; HUMANS; STENTS; THROMBOLYTIC THERAPY; TREATMENT FAILURE;

EID: 0033935292     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-726X(200007)50:3<269::AID-CCD1>3.0.CO;2-K     Document Type: Article

References (32)

1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360.
2. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-1622.
3. den Heijer P, Vermeer F, Ambrosioni E, Sadowski Z, Lopez-Sendon JL, von Essen R, Beaufils P, Thadani U, Adgey J, Pierurd L, Brinker J, Davies RF, Smalling RW, Wallentin L, Caspi A, Pangerl A, Trickett L, Hauck C, Henry D, Chew P. Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase vs. alteplase. Circulation 1998;98: 2117-2125.
4. Grines CL. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Primary angioplasty - the strategy of choice. N Engl J Med 1996;335: 1313-1316.
5. Ellis SG, da Silva ER, Heyndrickx G, Talley JD, Cernigliaro C, Steg G, Spaulding C, Nobuyoshi M, Erbel R, Vassanelli C. Randomized comparison of rescue angiopiasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994;90:2280-2284.
6. Rogers WJ, Baim DS, Gore JM, Brown BG, Roberts R, Williams DO, Chesebro JH, Babb JD, Sheehan FH, Wackers FJ. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the thrombolysis in myocardial infarction (TIMI) Phase II-A trial. Circulation 1990;81:1457-1476.
7. Gibson CM, Cannon CP, Greene RM, Sequeira RF, Margorien RD, Leya F, Diver DJ, Baim DS, Braunwald E. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial. Am J Cardiol 1997;80:21-26.
8. Ross AM, Lundergan CF, Rohrbeck SC, Boyle DH, van den Brand M, Buller CH, Holmes Jr DR, Reiner JS. Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. GUSTO-1 Angiographic Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 1998;31: 1511-1517.
9. Ellis SG, Van de Werf F, Ribeiro-daSilva E, Topol EJ. Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials. J Am Coll Cardiol 1992;19:681-686.
10. Gurbel PA, Serebruany VL, Shustov AR, Bahr RD, Carpo C, Ohman EM, Topol EJ. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global use of strategies to open occluded coronary arteries. J Am Coll Cardiol 1998;31:1466-1473.
11. Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990;322:33-42.
12. CORAMI Study Group. Outcome of attempted rescue coronary angioplasty after failed thrombolysis for acute myocardial infarction. The cohort of rescue angioplasty in myocardial infarction. Am J Cardiol 1994;74:172-174.
13. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495.
14. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.
15. Antoniucci D, Santoro GM, Bolognese L, Valenti R, Trapani M, Fazzini PF. A clinical trial comparing primary stenting of the infaret-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. J Am Coll Cardiol 1998;31:1234-1239.
16. Stone GW, Brodie BR, Griffin JJ, Morice MC, Costantini C, St. Goar FG, Overlie PA, Popma JJ, McDonnell J, Jones D, O'Neill WW, Grines CL. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 1998;31:23-30.
17. Mahdi NA, Lopez J. Leon M, Pathan A, Harrell L, Jang IK, Palacios IF. Comparison of primary coronary stenting to primary balloon angioplasty with stent bailout for the treatment of patients with acute myocardial infarction. Am J Cardiol 1998;81:957-963.
18. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KKL, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE. A clinical trial comparing three antithromboticdrug regimens after coronary-artery stenting. N Engl J Med 1998; 339:1665-1671.
19. Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The global use of strategies to open occluded coronary arteries in acute coronary syndromes (GUSTO IIb). N Engl J Med 1997;336:1621-1628.
20. Gibson CM, Sandor T, Stone PH, Pasternak RC, Rosner B, Sacks FM, Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol 1992;69:1286-1290.
21. Gibson CM, Cannon CP, Daley WL, Dodge Jr JT, Alexander Jr B, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888.
22. Savage MP, Douglas Jr JS, Fischman DL, Pepine CJ, King 3rd SB, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med 1997;337:740-747.
23. Sirnes PA, Golf S, Myreng Y, Molstad P, Albertsson P, Mangschau A, Endresen K, Kjekshus J. Sustained benefit of stenting chronic coronary occlusion: long-term clinical follow-up of the Stenting in Chronic Coronary Occlusion (SICCO) study. J Am Coll Cardiol 1998;32:305-310.
24. Stone GW, Brodie BR, Griffin JJ, Costantini C, Morice MC, St Goar FG, Overlie PA, Popma JJ, McDonnell J, Jones D, O'Neill WW, Grines CL. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: the primary angioplasty in myocardial infarction (PAMI) Stent Pilot Trial. Circulation 1999;99:1548-1554.
25. Urban P, Macaya C, Rupprecht HJ, Kiemeneij F, Emanuelsson H, Fontanelli A, Pieper M, Wesseling T, Sagnard L. Randomized evaluation of anticoagulation vs. antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation 1998;98:2126-2132.
26. O'Neill WW, Weintraub R, Grines CL, Meany TB, Brodie BR, Friedman HZ, Ramos RG, Gangadharan V, Levin RN, Choksi N. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty vs. lone angioplasty therapy of acute myocardial infarction. Circulation 1992;86:1710-1717.
27. Moreno R, Garcia E, Abeytua M, Soriano J, Elizaga J, Botas J, Lopez-Sendon JL, Delcan JL. Coronary stenting during rescue angioplasty after failed thrombolysis. Cathet Cardiovasc Intervent 1999;47:1-5.
28. Sundlof DW, Rerkpattanapitat P, Wongpraparaut N, Pathi P, Kotler MN, Jacobs LE, Ledley GS, Yazdanfar S. Incidence of bleeding complications associated with abciximab use in conjunction with thrombolytic therapy in patients requiring percutaneous transluminal coronary angioplasty. Am J Cardiol 1999;83:1569-1571.
29. Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Lucas J, Scherer J, Andersen K, Van de Werf F, Braunwald E. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis In myocardial infarction (TIMI) 14 trial. Circulation 1999;99:2720-2732.
30. Tenaglia AN, Fortin DF, Califf RM, Frid DJ, Nelson CL, Gardner L, Miller M, Navetta FI, Smith JE, Tcheng JE. Predicting the risk of abrupt vessel closure after angioplasty in an individual patient. J Am Coll Cardiol 1994;24:1004-1011.
31. Ellis SG, Roubin GS, King SB, Douglas Jr JS, Weintraub WS, Thomas RG, Cox WR. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988;77:372-379.
32. Dauerman HL, Pinto DS, Ho KKL, Gibson CM, Kuntz RE, Cohen DJ, Baim DS, Carrozza Jr JP. Outcome of patients with acute inyocardial infarction who are ineligible for primary angioplasty trials. Cathet Cardiovasc Intervent 2000:49:237-243.